Quture/TCLN Announces Application Partnership With InterSystems
23 August 2011 - 1:00PM
Marketwired
Techs Loanstar, Inc. (OTCQB: TCLN)
(PINKSHEETS: TCLN) and
Quture, Inc.
("Quture") immediately followed their merger with an announcement
that they are aggressively seeking to develop their new
"transformative" and "disruptive" tool to improve health care while
reducing costs on the
InterSystems
Corporation (www.InterSystems.com) integrated technology.
The Application Partnership Agreement signed between the parties
is now the focus of a Demonstration Project that includes Keith
Candiotti, M.D., Director of Clinical Research, Department of
Anesthesiology, Jackson Memorial Hospital and University of Miami
Medical School. The extensive intellectual property of Quture is
embedded in the Company's soon-to-be announced product on the
InterSystems platform. InterSystems and Quture hope to soon jointly
announce the success of this Demonstration after its application
with selected performance and outcomes measures by Dr.
Candiotti.
The Demonstration will prove the use of electronic data
integration and analytics to transform existing labor-intensive,
anecdotal, and vital quality and risk management processes to rapid
and enterprise-wide electronic processes.
"This is another big step forward in our development," said
Landon Feazell, CEO of Quture. "The collaboration between Dr.
Candiotti and Dr. Janice J. Ophoven, as previously announced, in
using the incredible technology platform of InterSystems is a
significant milestone."
InterSystems Ensemble® will be used for data integration to
capture clinical data from any vendor's electronic medical records
and software into the InterSystems CACHÉ® high performance object
database. InterSystems integrated technology is aptly-suited to
harness and support the power of Quture's intellectual property.
Additionally the Demonstration will utilize InterSystems DeepSee™
for embedded real-time business intelligence capabilities package
for health care enterprise management that is so desperately needed
by physicians, clinicians, administration, boards and the quality
and patient safety professionals in hospitals and physician groups
in America and internationally.
Added Feazell: "It is truly remarkable that InterSystems'
integrated technology is fully developed and deployed to satisfy
our requirements and specifications. We believe we can solve the
problems of disparate databases and silos of information that have
limited our endeavors for over 35 years of clinical performance
measurement in health care. This is a pivotal juncture in health
care and its impact on the American economy and on the lives of
patients and the professionals devoted to caring for them. We will
be proud to introduce these new tools to accomplish our mission and
to exceed and bring new capability to the extensive new federal and
national mandates and standards."
About Quture
Quture, Inc., a Nevada corporation, is positioned to rapidly
become the international standard in healthcare performance and
outcomes measurement and analytics to accomplish its corporate
mission. Quture provides healthcare organizations, insurers,
government payers, and other stakeholders in the healthcare
community with performance measurement tools and data sets.
Industry experts agree that performance and outcomes measurement is
the "transformative tool" to reduce medical cost and improve
quality of care. Quture's management team has 35 years of
experience and a long history of working with many of the nation's
leading healthcare institutions as a leader and innovator in
measuring clinical performance. Quture is now testing its
revolutionary solution to effectively and efficiently measure
clinical performance from multiple vendor databases.
Forward-Looking Statements
This release contains forward-looking statements, including,
without limitation, statements concerning our business and possible
or assumed future results of operations. Our actual results could
differ materially from those anticipated in the forward-looking
statements for many reasons including: our ability to continue as a
going concern, adverse economic changes affecting markets we serve;
competition in our markets and industry segments; our timing and
the profitability of entering new markets; greater than expected
costs, customer acceptance of our products or difficulties related
to our integration of the businesses we may acquire; and other
risks and uncertainties as may be detailed from time to time in our
public announcements and SEC filings. Although we believe the
expectations reflected in the forward-looking statements are
reasonable, they relate only to events as of the date on which the
statements are made, and our future results, levels of activity,
performance or achievements may not meet these expectations. We do
not intend to update any of the forward-looking statements after
the date of this document to conform these statements to actual
results or to changes in our expectations, except as required by
law.
For Further Information Contact: Constellation Asset Advisors,
Inc. Jens Dalsgaard President +1 (415) 524-8500